Pfizer (PFE)
(Delayed Data from NYSE)
$28.35 USD
+0.63 (2.27%)
Updated Jul 10, 2024 04:01 PM ET
After-Market: $28.27 -0.08 (-0.28%) 7:16 PM ET
3-Hold of 5 3
B Value F Growth B Momentum C VGM
Price, Consensus and EPS Surprise
PFE 28.35 +0.63(2.27%)
Will PFE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PFE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PFE
Is GSK an Attractive Drug Stock to Add to Your Portfolio Now?
Pfizer (PFE) Stock Slides as Market Rises: Facts to Know Before You Trade
PFE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD
Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Other News for PFE
GLOBAL BROKER RATINGS: Citigroup raises Next, BofA cuts Mastercard
Evotec and Pfizer enter multi-year research collaboration in France
IN BRIEF: Pfizer Chief Scientific Officer Dolsten to retire
Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development
This Is What Whales Are Betting On Pfizer